Joseph E Palys

Array ( [id] => 3784105 [patent_doc_number] => 05736319 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-07 [patent_title] => 'Attenuated gentically-engineered pseudorabies virus S-PRV-155 and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/456509 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9497 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/736/05736319.pdf [firstpage_image] =>[orig_patent_app_number] => 456509 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3881963 [patent_doc_number] => 05714141 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-03 [patent_title] => 'Use of interleukin 7 to enhance humoral immunity' [patent_app_type] => 1 [patent_app_number] => 8/458032 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 23 [patent_no_of_words] => 10212 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/714/05714141.pdf [firstpage_image] =>[orig_patent_app_number] => 458032 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3690729 [patent_doc_number] => 05691449 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-25 [patent_title] => 'Respiratory syncytial virus vaccines' [patent_app_type] => 1 [patent_app_number] => 8/450070 [patent_app_country] => US [patent_app_date] => 1995-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 18 [patent_no_of_words] => 26306 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/691/05691449.pdf [firstpage_image] =>[orig_patent_app_number] => 450070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3725143 [patent_doc_number] => 05672689 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-30 [patent_title] => 'Non-cleavable GP160 glycoproteins of HIV' [patent_app_type] => 1 [patent_app_number] => 8/442995 [patent_app_country] => US [patent_app_date] => 1995-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8520 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/672/05672689.pdf [firstpage_image] =>[orig_patent_app_number] => 442995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3857291 [patent_doc_number] => 05795579 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-18 [patent_title] => 'Herpes simplex virus VP16 vaccines' [patent_app_type] => 1 [patent_app_number] => 8/442980 [patent_app_country] => US [patent_app_date] => 1995-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 13180 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/795/05795579.pdf [firstpage_image] =>[orig_patent_app_number] => 442980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3690022 [patent_doc_number] => 05696238 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-09 [patent_title] => 'Purified GP120 composition retaining natural conformation' [patent_app_type] => 1 [patent_app_number] => 8/439286 [patent_app_country] => US [patent_app_date] => 1995-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 33 [patent_no_of_words] => 21081 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/696/05696238.pdf [firstpage_image] =>[orig_patent_app_number] => 439286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3701705 [patent_doc_number] => 05653985 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-05 [patent_title] => 'Purified gp120 composition retaining natural conformation' [patent_app_type] => 1 [patent_app_number] => 8/439119 [patent_app_country] => US [patent_app_date] => 1995-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 33 [patent_no_of_words] => 21044 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/653/05653985.pdf [firstpage_image] =>[orig_patent_app_number] => 439119 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3726071 [patent_doc_number] => 05702918 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-30 [patent_title] => 'HIV-2 envelope polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/435937 [patent_app_country] => US [patent_app_date] => 1995-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 9876 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/702/05702918.pdf [firstpage_image] =>[orig_patent_app_number] => 435937 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4002464 [patent_doc_number] => 05961977 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Method of treating or preventing autoimmune uveoretinitis in mammals' [patent_app_type] => 1 [patent_app_number] => 8/419505 [patent_app_country] => US [patent_app_date] => 1995-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 11975 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/961/05961977.pdf [firstpage_image] =>[orig_patent_app_number] => 419505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3843015 [patent_doc_number] => 05766601 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Cross-reactive influenza a immunization' [patent_app_type] => 1 [patent_app_number] => 8/419513 [patent_app_country] => US [patent_app_date] => 1995-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6921 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/766/05766601.pdf [firstpage_image] =>[orig_patent_app_number] => 419513 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3788127 [patent_doc_number] => 05725851 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-10 [patent_title] => 'Method and compositions for treating injury' [patent_app_type] => 1 [patent_app_number] => 8/411224 [patent_app_country] => US [patent_app_date] => 1995-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 5533 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/725/05725851.pdf [firstpage_image] =>[orig_patent_app_number] => 411224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3604243 [patent_doc_number] => 05589175 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-31 [patent_title] => 'Peptides for induction of neutralizing antibodies against human immunodeficiency virus' [patent_app_type] => 1 [patent_app_number] => 8/410384 [patent_app_country] => US [patent_app_date] => 1995-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9110 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/589/05589175.pdf [firstpage_image] =>[orig_patent_app_number] => 410384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3878691 [patent_doc_number] => 05798090 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-25 [patent_title] => 'Enhancement of the cellular immune response' [patent_app_type] => 1 [patent_app_number] => 8/394431 [patent_app_country] => US [patent_app_date] => 1995-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 3378 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/798/05798090.pdf [firstpage_image] =>[orig_patent_app_number] => 394431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3903154 [patent_doc_number] => 05927003 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-27 [patent_title] => 'Polymeric media amendment' [patent_app_type] => 1 [patent_app_number] => 8/393807 [patent_app_country] => US [patent_app_date] => 1995-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 44 [patent_no_of_words] => 10536 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/927/05927003.pdf [firstpage_image] =>[orig_patent_app_number] => 393807 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3889635 [patent_doc_number] => 05750110 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-12 [patent_title] => 'Vaccine composition containing adjuvants' [patent_app_type] => 1 [patent_app_number] => 8/356372 [patent_app_country] => US [patent_app_date] => 1995-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4280 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/750/05750110.pdf [firstpage_image] =>[orig_patent_app_number] => 356372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3682993 [patent_doc_number] => 05662909 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-02 [patent_title] => 'Potentiation of immunogenic response' [patent_app_type] => 1 [patent_app_number] => 8/385587 [patent_app_country] => US [patent_app_date] => 1995-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 2951 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/662/05662909.pdf [firstpage_image] =>[orig_patent_app_number] => 385587 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3623141 [patent_doc_number] => 05686078 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-11 [patent_title] => 'Primary and secondary immunization with different physio-chemical forms of antigen' [patent_app_type] => 1 [patent_app_number] => 8/385586 [patent_app_country] => US [patent_app_date] => 1995-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 1430 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/686/05686078.pdf [firstpage_image] =>[orig_patent_app_number] => 385586 [rel_patent_id] =>[rel_patent_doc_number] =>)